ISSN ONLINE: 2558-815X
ISSN PRINT: 1584-9244
ISSN-L: 1584-9244

Warfarin Linked to Lower Cancer Risk


On November 6, 2017, a new study from Norway was published in JAMA Internal Medicine, in connection with the benefit of using anticoagulants. It was discovered that the use of the anticoagulant warfarin may protect against a broad range of cancers in people over age 50. During the 7-year observation period, 132,687 participants were diagnosed with cancer. Compared with nonusers of warfarin, users of warfarin had significantly lower age- and sex-adjusted rates of all cancers and of cancer of the lung, prostate, and breast, but not the colon. (


Comments are closed.